on ENERGISME (EPA:ALNRG)
Loamics, a subsidiary of Energisme, records its first revenue
Loamics, a subsidiary of Energisme focused on health data management, achieved its first revenue in 2025. This milestone underlines Loamics' economic maturity and its ability to create value within the P4DP Consortium, a national health data warehouse.
For 2025, Loamics achieved a turnover of over €500,000, with even higher projections for 2026. This growth is accompanied by the participation of strategic partners such as Doctolib and Weda, thus enriching the primary care database. The system is scheduled to go live in the second quarter of 2026.
Energisme is exploring the possibility of bringing in an investor for Loamics, valued at over €20 million. These developments will be presented at the ALLINVEST SECURITIES BIOMED FORUM dedicated to Biotech/Medtech.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ENERGISME news